Tickerover
Healthcare

ILMN Stock Analysis

Illumina, Inc. · current price $215.65 (-5.27% today)

Solid setup — 4/4 EPS beats. Caveat: trades 7.8% above analyst mean target. Stock is trading above the analyst mean target ($199) — limited consensus headroom.
★★★★
Quality
📊

The six-pillar scorecard

Momentum
76
Trending up strong
price trend
Growth
25
Barely growing
sales & profit growth
Quality
99
High quality
profitability & balance sheet
Valuation
25
Expensive
is the price fair?
Sentiment
32
Out of favour
analyst & crowd mood
Risk
52
Moderate risk
volatility & drawdown

Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.

📉

The picture

What drove the scoreThe seven components contributing most, each read out of 100.
RSI zoneRSI zone: 100100Trend strengthTrend strength: 1001001-month momentum1-month momentum: 6262Relative strengthRelative strength: 8585Earnings qualityEarnings quality: 8989GrowthGrowth: 3838Breakout proximityBreakout proximity: 6363
Margin profileWhat survives each step down the income statement.
GrossGross: 67.9%67.9%OperatingOperating: 21.1%21.1%NetNet: 18.3%18.3%Free cash flowFree cash flow: 21.5%21.5%
EPS surpriseReported EPS against estimate, last four quarters.
2026-06: +6.8% vs estimate+7%2026-062026-03: +9.0% vs estimate+9%2026-032025-12: +9.7% vs estimate+10%2025-122025-09: +14.7% vs estimate+15%2025-09
👁

Hype Check

Reading ILMN’s price and volume history…

The audit — what has to hold for this thesis

Checking the areas that decide this thesis…

AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.

🛡

Dilution Check

Reading ILMN’s filings…

📣

Latest earnings

LAST EARNINGS Illumina, Inc. (ILMN)

Latest earnings

EPS
$1.34 vs $1.17 est · +14.7% vs estimate BEAT
Stock reaction (1M)
+5.1%
Beat streak
4 of last 4 quarters
💰

Valuation

P/E
42.5×
Forward P/E
35.4×
PEG
3.23
Price / Sales
7.2×
Price / Book
11.5×
EV / EBITDA
29.4×
Analyst target
$198.89
Target range
$113.00 – $230.00
Implied upside
-7.8%
🩺

Financial health

Gross margin
67.9%
Operating margin
21.1%
Net margin
18.3%
FCF margin
21.5%
Return on equity
32.3%
Debt / equity
0.89
Revenue growth YoY
+9.4%
EPS growth YoY
-9.4%
📈

Technicals

$88.0052-week range$231.81
RSI (14)
60
50-day MA
$193.52
200-day MA
$149.53
ATR (14)
9.33
Beta
1.46
1-month return
+5.1%
🗓️

Earnings

QuarterEPSEst.SurpriseResult
2025-09-30$1.34$1.17+14.7%Beat
2025-12-31$1.35$1.23+9.7%Beat
2026-03-31$1.15$1.05+9.0%Beat
2026-06-30$1.31$1.23+6.8%Beat
Beat 4 of the last 4 quarters.
🏛️

Ownership & risk

Short % of float
0.10%
Beta
1.46
📰

Latest news on ILMN

🔗

Similar stocks in Healthcare

Frequently asked

What is ILMN's Quant Score?

Illumina, Inc. (ILMN) currently has a TickerMover Quant Score of 65/100, rated ★★★★ Quality. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Illumina, Inc. (ILMN) a buy?

TickerMover does not give buy or sell recommendations. ILMN scores 65/100 (★★★★ Quality) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is ILMN's score updated?

ILMN's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.

Open the dashboard for ILMN →